Stricter compliance procedures eyed by Indian pharma

09/29/2013 | Business Standard (India)

Top Indian drugmakers say they need stricter compliance procedures and greater investment in quality to maintain their share in the global market amid concerns about increasing global enforcements. "Domestic companies represent a significant part of the global drug industry and, therefore, there is an increase in the scrutiny of these companies," Biocon Chairman and Managing Director Kiran Mazumdar-Shaw said. Audits are more frequent than earlier periodic reviews because of the U.S. FDA's presence in the country now, she said.

View Full Article in:

Business Standard (India)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ